
Efficacy and safety of OBI-1, an antihaemophilic factor VIII ...
Acquired haemophilia A (AHA) is a rare bleeding disorder caused by autoantibodies against human factor VIII (hFVIII). OBI-1 is an investigational, B-domain deleted, recombinant FVIII, …
Obi-Wan Kenobi - Wikipedia
Obi-Wan " Ben " Kenobi (/ ˈoʊbiːˌwɑːn kəˈnoʊbiː /) is a character in the Star Wars franchise. In the original film trilogy, he is a Jedi Master who trains Luke Skywalker in the ways of the Force. In …
OBI1 Gene - GeneCards | OBI1 Protein | OBI1 Antibody
2024年12月25日 · OBI1 (ORC Ubiquitin Ligase 1) is a Protein Coding gene. Diseases associated with OBI1 include Bladder Small Cell Carcinoma and Factor Viii Deficiency. E3 ubiquitin ligase …
Porcine recombinant factor VIII (Obizur; OBI-1; BAX801): product ...
Obizur is a highly purified recombinant porcine FVIII drug product that has been demonstrated to have a favourable safety and efficacy profile when compared with Hyate:C and can be a …
OBI-1, porcine recombinant Factor VIII for the potential ... - PubMed
OBI-1 has the procoagulant and biochemical properties of porcine pdFVIII, with improvements in risk of toxicity, infection and ease of manufacture. OBI-1 demonstrated significantly less …
Efficacy and safety of OBI-1, an antihaemophilic factor VIII ...
2015年1月27日 · OBI-1 is an investigational, B-domain deleted, recombinant FVIII, porcine sequence, with low cross-reactivity to anti-hFVIII antibodies. Efficacy can be monitored with …
Recombinant B-Domain Deleted Porcine Factor VIII (OBI-1) Safety …
2012年11月16日 · OBI-1 is an investigational B-domain deleted recombinant porcine factor VIII (FVIII) with low cross-reactivity to anti-human FVIII antibodies. Acquired hemophilia A (AHA) is …
猪重组因子VIII(Obizur; OBI-1; BAX801):产品特性和临床前概 …
重组pFVIII(rpFVIII),Obizur(OBI-1; BAX801)有望与Hyate:C具有相似的功效,但安全性更高,因此已开发出来,最近获得了美国食品药品监督管理局的批准。
Recombinant B-Domain Deleted Porcine Factor VIII (OBI-1) Safety …
2012年11月16日 · OBI-1 is an investigational B-domain deleted recombinant porcine factor VIII (FVIII) with low cross-reactivity to anti-human FVIII antibodies. Acquired hemophilia A (AHA) is …
A Phase II Open-Label Study Evaluating Hemostatic Activity ...
2007年11月16日 · OBI-1, a recombinant B-domain deleted pFVIII, has recently been tested in a Phase II trial in patients with congenital hemophilia A and inhibitors experiencing a non-life/non …
- 某些结果已被删除